NAFDAC DG Pays a Working Visit to Emzor Campus in Shagamu
Source: UGC
Director Drug Evaluation and Research, NAFDAC Mrs IjeomaNwankwo; Founder and Group Managing Director of Emzor Pharmaceuticals Dr Stella C Okoli; Director-General, NAFDAC Prof Mojisola Adeyeye; Director Registration and Regulatory Dr Monica Eimunjeze; Director Drug Evaluation and Research Mrs Ijeoma Nwankwo; and Special Assistant to the Dg Dr Olugbenga Fajemirokun, during a working visit of the NAFDAC DG to Emzor Campus, in Ogun State.
About Emzor
Emzor is a privately owned indigenous pharmaceutical company founded in 1984 by Dr. Stella Okoli. The Company has grown into a legacy pharmaceutical company with 4 modern factories that manufacture over 140 world-class pharmaceutical products, such as analgesics (the widely used Emzor Paracetamol), vitamins, haematinics, anti-malarial, anti-tussive, antibiotics, antihelminthic, anti-histamine, antacid, and cardio-protective drugs. Emzor has a network of over 120 distributors covering public and private institutions across West Africa. Emzor is the largest indigenous pharmaceuticals manufacturer in the country with over 120 products, all NAFDAC approved.
Source: UGC
THE FACTORY VISIT
The NAFDAC Director-General, Prof. Mojisola Adeyeye in the company of Dr Monica Eimunjeze (Director, Drug Registration And Regulatory Affairs (DRRA); Mrs Ijeoma Nwankwo, U. (Director, Drug Evaluation & Research (DER) and Dr Gbenga Fajemirokun (SA-DG NAFDAC) visited the Ultra-Modern Pharma Factory known as Emzor Campus. The World Health Organization (WHO) compliant factory is sited on more than 60 Hectares of land at the Shagamu Interchange of the Lagos – Ibadan Expressway and is the largest pharmaceutical facility in West Africa. The factory is also (cGMP) compliant and has already manufactured and supplied millions of doses of medication ranging from antimalarials, paediatric care, vitamins and antiretrovirals to various international organizations through partnerships for public health intervention.
DURING THE VISIT
MRS. Uzoma Ezeoke the EDG. Emzor briefed the NAFDAC team on the Emzor Emzor group’s progress from inception to date. She said that the company has grown from the days of drug sales & marketing to manufacturing for the local and African market to exportation to UK and Netherlands in Europe and the United States of America. This is in line with the Emzor group’s goal to be the number one name in pharmaceuticals on the African continent.
After the NAFDAC teams tour of the Factory; the team addressed their host, the Emzor group.
Source: UGC
The NAFDAC DG, Professor Mojisola Adeyeye says “I taught pharmaceutical manufacturing in the United States for 19 years and I usually would take my students to pharmaceutical companies as an extension of the class because I believe in experiential. Part of the training is the facility tour. This facility that we have seen today can stand beside any facility in the US. To see what Emzor is doing gladdens my heart and makes us know that we can do it”.
She commended the Emzor workforce on their dedication and commitment to the vision of Dr Stella Okoli for the pharmaceuticals industry in Nigeria as well as upholding the standards set by NAFDAC under the management’s new structure and standards in the last three years to regulate the pharmaceutical industry in line with global best practices regulatory bodies. She particularly praised the Emzor group consumer-targeted production and Health, Safety and Environment (HSE) compliance. She
Source: Legit.ng
